Local active immunotherapy for malignant melanoma.
D001500:BCG Vaccine / Q000627:therapeutic use*; D003176:Complement C3 / Q000032:analysis; D003165:Complement System Proteins / Q000032:analysis; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D007167:Immunotherapy; D008545:Melanoma / Q000628:therapy*
D001500:BCG Vaccine; D003176:Complement C3; D007136:Immunoglobulins; D003165:Complement System Proteins